ER Niacin/Laropiprant

extended-release niacin and laropiprant combination · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ER Niacin/Laropiprant, covering 2009-02-05 to 2009-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) [Phase 1]

See pricing